Sorin Buga

Sorin Buga

Auto-generated profile, based on publicly available information

Sorin Buga

City of Hope National Medical Center, Duarte, CA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Journal of Hospice & Palliative Nursing
Verified
Journal Article
Closed access
TBTami Rn Borneman
Tami Rn Borneman
VSVirginia Sun
Virginia Sun
AWAnna Cathy Rn Williams
Anna Cathy Rn Williams
RFRebecca Fujinami
Rebecca Fujinami
CFCatherine Msn Del Ferraro
Catherine Msn Del Ferraro
SBSorin Md Buga
Sorin Md Buga
Consistent with the recommendations of the Institute of Medicine Report on quality cancer care, attention to symptom management and quality of life concerns of patients with lung cancer should be addressed throughout the disease trajectory. As part of an National Cancer Institute-funded Program Project grant, this article reports on the patient and family caregiver education component of a nurse-lead, tailored, palliative care intervention for patients with early-stage (I-III, n = 130) and late-stage (IV, n = 142) lung cancer. Patients and family caregivers received 4 separate educational sessions organized around the Quality of Life model domains (physical, psychological, social, and spiritual well-being). Each patient and caregiver was presented at a weekly interdisciplinary case conference, which also informed the educational sessions. Based on needs and team suggestions, an individualized palliative care plan was created and a tailored educational intervention was designed based on topics chosen by each participant. The most common topics chosen by patients in each domain were fatigue, worry and fear, social support/isolation, and hope. Family caregivers most commonly chose fatigue, worry and fear, communication, and purpose and meaning in life. The time spent in each teaching session ranged from 31 to 44 minutes for patients and 25 to 35 minutes for family caregivers. There is a vital need for interdisciplinary palliative care interventions for patients across all stages and across the disease trajectory. Nurses are vital to integrating palliative care into routine care. Providing a tailored educational intervention is an important aspect of palliative care for patients and family caregivers. This article focuses on the process of the tailored educational intervention.

8 February 2018
Verified
Book Chapter
Closed access
PDF file
SBSorin Buga
Sorin Buga
CBChandana Banerjee
Chandana Banerjee
JSJaroslava Salman
Jaroslava Salman
MCMarissa Cangin
Marissa Cangin
FZFinly Zachariah
Finly Zachariah
BFBonnie Freeman
Bonnie Freeman

19 October 2023
Verified
Book Chapter
Closed access
PDF file
NPNoah Pujanes-Mantor
Noah Pujanes-Mantor
SBSorin Buga
Sorin Buga

1 July 2018 in Cureus
Verified
Journal Article
Open access
PDF file
DFDoron Feinsilber
Doron Feinsilber
MRMarco Ruiz
Marco Ruiz
SBSorin Buga
Sorin Buga
LHLeigh A Hatch
Leigh A Hatch
AHAndrew D. Hatch
Andrew D. Hatch
KMKatrina A Mears
Katrina A Mears
The molecular characterization of solid tumor malignancies with respect to tumorgenesis, risk stratification, and prognostication of chemotherapeutic side effects is multi-faceted. Characterizing these mechanisms requires a detailed understanding of cytogenetics and pharmacology. In addition to the standard palliative care interventions that address issues such as fatigue, neuropathy, performance status, depression, nutrition, cachexia, anxiety, and medical ethics, we must also delve into individual chemotherapy side effects. Comprehending these symptoms is more complex with the advent of broader targeted therapies. With the advent and initiation of Foundation Medicine (FMI) testing, we have been able to tailor regimens to the individual genetics of the patient. Next-generation sequencing (NGS) is a bioinformatic analysis used in order to create a targeted effort to understand the complex genetics of a vast array of malignancies. Through the process known as high-throughput sequencing we, as clinicians, can obtain more real-time genetic data and incorporate the information into our reasoning process. The process involves a broad manner in which deoxyribonucleic acid (DNA) sequence data is obtained including genome sequencing and resequencing, protein-DNA or proteinomics, chromatin immunoprecipitation (ChIP)sequencing, ribonucleic acid (RNA) sequencing, and epigenomic analysis. High-throughput sequencing techniques including single molecule real-time sequencing, ion semiconductor sequencing, pyrose sequencing, sequencing by synthesis, sequencing by ligation, nanopore sequencing, and chain termination (otherwise known as Sanger sequencing) have expanded the realm of NGS and clinicians options.

1 November 2017 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
FZFinly Zachariah
Finly Zachariah
LPLeslie Popplewell
Leslie Popplewell
SFStephen J. Forman
Stephen J. Forman
GGGerardo Gorospe
Gerardo Gorospe
JWJudy Wong-Toh
Judy Wong-Toh
JAJoseph C. Alvarnas
Joseph C. Alvarnas
16 Background: Advance Care Planning (ACP) is central to patient-centered care and helps assure treatment aligns with a patient’s goals, values, and priorities. ACP is often poorly incorporated into the hematopoietic stem cell transplantation (HSCT) population, with reported advance directive (AD) rates of 23-50%. At City of Hope National Medical Center (COH), concerted efforts to improve the overall number of ADs in HSCT was undertaken and evaluated. Methods: The Department of Supportive Care Medicine at COH, in collaboration with medical faculty and administrative support, created a patient-centered ACP program. The first two years (2013/2014) broadly focused on all new COH patients. The last two years (2015/2016) included a specific focus on patients undergoing HSCT. The primary goal was a completed AD in the electronic medical record before day 0 of transplant. In addition to provider and transplant team engagement, major time points for supportive care integration to facilitate AD completion were identified including: 1) registration, 2) new patient orientation, 3) the clinical visit when transplant was decided, 4) pre-transplant education class, 5) clinical social work psychosocial assessment visit, and 6) the pre-transplant hospital days. AD completion rates were calculated with Odds Ratio and Mantel-Haenszel Chi-Square using Epi Info StatCalc. Results: Between 2012 and 2016 at COH, 1784 transplants were performed. For HSCT patients in 2012, baseline AD capture rate before day 0 of transplant was 28.6%. With the institutional AD program, the AD capture rate before day 0 of transplant was 31.6% for 2014, compared with 2012 [odds ratio, 1.17(95% CI, 0.85-1.60); p = .33]. With both institutional and hematology specific programs, AD capture rate before day 0 was 69.5% for 2016, compared to 2014[odds ratio, 4.30 (95% CI, 3.14-5.91); p < .001]. Conclusions: Compared to 2012, the institutional AD program in 2014 insignificantly impacted HSCT AD completion rates. Improving the rate of AD completion from 28.6% to 69.5% in HSCT patients required both institutional AD efforts and a targeted program. Nevertheless, more work is needed to improve AD completion rates before transplant to 100%.

1 January 2025 in Oncolog-Hematolog.ro
Verified
Journal Article
Closed access
RMRafik Mughnetsyan
Rafik Mughnetsyan
DWDemi Wolford
Demi Wolford
ATAndrada-Daniela Totoran
Andrada-Daniela Totoran
SBSorin Buga
Sorin Buga
Taste disturbances are a frequent and often under­ap­pre­cia­ted complication of chemotherapy or radiotherapy. Al­though these disturbances are generally not life-threate­ning, they warrant clinical attention due to their potential to substantially impact patients’ quality of life and ad­he­rence to treatment regimens. Taste alterations can be clas­si­fied into various categories based on the quality of the chan­ges, and their severity can be assessed using tools such as the Common Terminology Criteria for Adverse Events (CTCAE) and the Scale of Subjective Total Taste Acuity (STTA). The European Society for Medical Oncology (ESMO) re­com­mends that healthcare providers inform patients ex­pe­rien­cing chemotherapy- or radiotherapy-induced taste disturbances about available dietary counseling and self-care strategies. While some studies have demonstrated pro­mi­sing results with interventions such as zinc sup­ple­men­ta­tion (notably polaprezinc), dronabinol and megestrol ace­tate, further research is necessary to establish their ef­fi­cacy and broader clinical applicability.